Compare BBY & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBY | RVTY |
|---|---|---|
| Founded | 1966 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.8B |
| IPO Year | 1994 | 1994 |
| Metric | BBY | RVTY |
|---|---|---|
| Price | $62.57 | $85.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 15 |
| Target Price | $78.58 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 4.6M | 1.0M |
| Earning Date | 03-03-2026 | 04-27-2026 |
| Dividend Yield | ★ 5.98% | 0.33% |
| EPS Growth | ★ 17.76 | N/A |
| EPS | ★ 5.04 | 2.07 |
| Revenue | ★ $41,691,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $1.22 | $6.34 |
| Revenue Next Year | $1.39 | $5.10 |
| P/E Ratio | ★ $12.76 | $41.47 |
| Revenue Growth | ★ 0.39 | N/A |
| 52 Week Low | $54.99 | $81.36 |
| 52 Week High | $84.99 | $118.30 |
| Indicator | BBY | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 33.32 |
| Support Level | $62.74 | $83.11 |
| Resistance Level | $69.26 | $94.75 |
| Average True Range (ATR) | 2.21 | 3.02 |
| MACD | 0.01 | -0.39 |
| Stochastic Oscillator | 13.31 | 14.14 |
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.